Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032? It is currently trading at a 50% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated October 16, 2026 at 2:18 AM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
50% 0.50 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
51% 51% 50%

Related Prediction Markets

Popular Prediction Markets